Skip to main content
main-content

Zeitschrift

Investigational New Drugs

Investigational New Drugs 6/2007

Ausgabe 6/2007

Inhaltsverzeichnis ( 9 Artikel )

01.12.2007 | PRECLINICAL STUDIES | Ausgabe 6/2007

Cell growth inhibition, G2M cell cycle arrest, and apoptosis induced by the novel compound Alternol in human gastric carcinoma cell line MGC803

Xia Liu, Jingze Wang, Bo Sun, Yajing Zhang, Jin Zhu, Changling Li

01.12.2007 | PRECLINICAL STUDIES | Ausgabe 6/2007

Targeting telomerase activity by BIBR1532 as a therapeutic approach in germ cell tumors

Sandra Mueller, Ulrike Hartmann, Frank Mayer, Stefan Balabanov, Joerg T. Hartmann, Tim H. Brummendorf, Carsten Bokemeyer

01.12.2007 | PRECLINICAL STUDIES | Ausgabe 6/2007

Pomolic acid-induced apoptosis in cells from patients with chronic myeloid leukemia exhibiting different drug resistance profile

F. C. Vasconcelos, C. R. Gattass, V. M. Rumjanek, R. C. Maia

01.12.2007 | PRECLINICAL STUDIES | Ausgabe 6/2007

Naphthylnitrobutadienes as pharmacologically active molecules: evaluation of the in vivo antitumour activity

Giovanni Petrillo, Carla Fenoglio, Emanuela Ognio, Cinzia Aiello, Domenico Spinelli, Maria A. Mariggiò, Massimo Maccagno, Stefano Morganti, Cinzia Cordazzo, Maurizio Viale

01.12.2007 | PHASE II STUDIES | Ausgabe 6/2007

A phase II clinical trial of ZD1839 (Iressa™) in combination with docetaxel as first-line treatment in patients with advanced breast cancer

Sheri K. Dennison, Samuel A. Jacobs, John W. Wilson, Janell Seeger, Terrence P. Cescon, Jane M. Raymond, Charles E. Geyer, Norman Wolmark, Sandra M. Swain

01.12.2007 | PHASE II STUDIES | Ausgabe 6/2007

A Phase II study of 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP) and gemcitabine in advanced pancreatic carcinoma. A trial of the Princess Margaret Hospital Phase II consortium

M. J. Mackenzie, D. Saltman, H. Hirte, J. Low, C. Johnson, G. Pond, M. J. Moore

01.12.2007 | PHASE II STUDIES | Ausgabe 6/2007

Phase II trial of alternating intravenous and oral vinorelbine in combination with cisplatin in advanced non-small cell lung cancer

Elisabetta Campagnoli, Isabella Garassino, Armando Santoro, Fabio De Vincenzo, Paolo Andrea Zucali, Giovanni Luca Ceresoli, Fabio Romano Lutman, Marco Alloisio, Hector Josè Soto Parra, Raffaele Cavina

01.12.2007 | PHASE II STUDIES | Ausgabe 6/2007

Phase II study of KOS-862 in patients with metastatic androgen independent prostate cancer previously treated with docetaxel

Tomasz M. Beer, Celestia S. Higano, Mansoor Saleh, Robert Dreicer, Gary Hudes, Joel Picus, Mark Rarick, Louis Fehrenbacher, Alison L. Hannah

01.12.2007 | PHASE III STUDIES | Ausgabe 6/2007 Open Access

Intravenous ATP infusions can be safely administered in the home setting: a study in pre-terminal cancer patients

Sandra Beijer, Eric A. R. Gielisse, Pierre S. Hupperets, Ben E. E. M. van den Borne, Marieke van den Beuken-van Everdingen, Marten R. Nijziel, Arjen M. J. van Henten, Pieter C. Dagnelie

Aktuelle Ausgaben

Neu im Fachgebiet Onkologie

Mail Icon II Newsletter

Bestellen Sie unseren kostenlosen Newsletter Update Onkologie und bleiben Sie gut informiert – ganz bequem per eMail.

Bildnachweise